Advancing Impurity and Residual Analysis to Strengthen mRNA Product Quality and QC Readiness

  •  Developing and optimizing assays to detect and quantify critical impurities and residuals including dsRNA, proteins, and DNA in mRNA therapeutics
  • Translating analytical rigor from development to QC to ensure reproducibility, compliance, and regulatory acceptance